Baker Michael S, Venturini Sara, Lindblad Caroline, Heihre Joshua M, Timofeev Ivan, Guilfoyle Mathew R, Hutchinson Peter J, Carpenter Keri L H, Helmy Adel
Division of Neurosurgery, Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.
Department of Medical Sciences, Section of Neurosurgery, Uppsala University, Uppsala, Sweden.
PLoS One. 2025 Sep 2;20(9):e0331310. doi: 10.1371/journal.pone.0331310. eCollection 2025.
We aimed to compare the prevalence and multimodal associations of mitochondrial dysfunction as defined by published cerebral-microdialysis-based criteria versus our novel multimodality-monitoring-based criteria in acute traumatic brain injury patients.
We retrospectively analyzed neurocritical care monitoring data from 619 acute traumatic brain injury patients. Monitoring modalities included cerebral microdialysis, intracranial pressure, brain tissue oxygenation, cerebral perfusion pressure, and the pressure reactivity index. The cerebral-microdialysis-based criteria we compared combine an elevated lactate/pyruvate ratio (25 or 30) with raised concentrations of lactate (2.5 mM) or pyruvate (70 μM or 120 μM). Our multimodality-monitoring-based criteria comprise a consistent lactate/pyruvate ratio > 25 with intracranial pressure ≤ 20 mmHg, brain tissue oxygenation ≥ 15 mmHg, a pressure reactivity index ≤ 0.3, and cerebral glucose ≥ 1.0 mM.
Across 592 analyzable patients, a lactate/pyruvate ratio > 25 was common, with a median prevalence of 48.9% (41.5% with consistency) and a U-shaped, bimodal distribution. A lactate/pyruvate ratio > 25 was associated with lower glucose and higher glycerol, and when accompanied by high pyruvate (> 120 μM), this derangement was further distinguished by higher glutamate and cerebral perfusion pressure. Using multimodal criteria on a cohort of 268 patients, consistent mitochondrial dysfunction was identified in 25.7% to 41.0% of patients, often in the absence of other physiological derangements.
Many acute traumatic brain injury patients constantly demonstrate neurometabolic derangements, among which clinical mitochondrial dysfunction is highly prevalent despite normal cerebral pressure, oxygenation, and perfusion. There is necessity for targeted, neurometabolic therapies in neurocritical care that address this abnormality.
我们旨在比较已发表的基于脑微透析的标准与我们基于多模态监测的新标准所定义的线粒体功能障碍在急性创伤性脑损伤患者中的患病率及多模态关联。
我们回顾性分析了619例急性创伤性脑损伤患者的神经重症监护监测数据。监测方式包括脑微透析、颅内压、脑组织氧合、脑灌注压和压力反应性指数。我们所比较的基于脑微透析的标准将升高的乳酸/丙酮酸比值(25或30)与升高的乳酸浓度(2.5 mM)或丙酮酸浓度(70 μM或120 μM)相结合。我们基于多模态监测的标准包括一致的乳酸/丙酮酸比值>25、颅内压≤20 mmHg、脑组织氧合≥15 mmHg、压力反应性指数≤0.3以及脑葡萄糖≥1.0 mM。
在592例可分析患者中,乳酸/丙酮酸比值>25很常见,中位患病率为48.9%(一致性为41.5%),呈U形双峰分布。乳酸/丙酮酸比值>25与较低的葡萄糖和较高的甘油相关,当伴有高丙酮酸(>120 μM)时,这种紊乱还表现为较高的谷氨酸和脑灌注压。在一组268例患者中使用多模态标准,25.7%至41.0%的患者被确定存在一致的线粒体功能障碍,且通常不存在其他生理紊乱。
许多急性创伤性脑损伤患者持续表现出神经代谢紊乱,其中临床线粒体功能障碍尽管脑压、氧合和灌注正常但仍高度普遍。在神经重症监护中针对这种异常进行有针对性的神经代谢治疗很有必要。